To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Xeljanz for PsA, extends PDUFA for UC

FDA approved sNDAs from Pfizer Inc. (NYSE:PFE) for Xeljanz (Jaquinus)

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE